A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery

Tianyan Ding1,2 *, Cantong Liu1,2 *, Binliang Huang,1,2 Lingyu Chu,1,2 Laifeng Wei,1,2 Yiwei Lin,1,2 Yun Luo,1,2 Biao Zhang,1,2 Chaoqun Hong,3 Yiwei Xu,1,2 Yuhui Peng1,2 1Department of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, Shantou, Peopl...

Full description

Bibliographic Details
Main Authors: Ding T, Liu C, Huang B, Chu L, Wei L, Lin Y, Luo Y, Zhang B, Hong C, Xu Y, Peng Y
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/a-survival-prediction-nomogram-for-esophageal-squamous-cell-carcinoma--peer-reviewed-fulltext-article-CMAR
_version_ 1819125897968484352
author Ding T
Liu C
Huang B
Chu L
Wei L
Lin Y
Luo Y
Zhang B
Hong C
Xu Y
Peng Y
author_facet Ding T
Liu C
Huang B
Chu L
Wei L
Lin Y
Luo Y
Zhang B
Hong C
Xu Y
Peng Y
author_sort Ding T
collection DOAJ
description Tianyan Ding1,2 &ast;, Cantong Liu1,2 &ast;, Binliang Huang,1,2 Lingyu Chu,1,2 Laifeng Wei,1,2 Yiwei Lin,1,2 Yun Luo,1,2 Biao Zhang,1,2 Chaoqun Hong,3 Yiwei Xu,1,2 Yuhui Peng1,2 1Department of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, Shantou, People’s Republic of China; 2Precision Medicine Research Center, Shantou University Medical College, Shantou, People’s Republic of China; 3Guangdong Provincial Key Laboratory of Breast Cancer Diagnosis and Treatment, Cancer Hospital of Shantou University Medical College, Shantou, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Yiwei XuDepartment of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, 515041, Guangdong, People’s Republic of ChinaFax +86-754-8856-0352Email yiwei512@126.comYuhui Peng Email pengyuhui666@163.comBackground: Neoadjuvant chemoradiotherapy (NCRT) followed by surgery is a component of the standard treatment for resectable locally advanced esophageal squamous cell carcinoma (ESCC), and the parameters for survival prediction are not clear yet. Our study aimed to construct a survival prediction nomogram for ESCC with NCRT followed by surgery.Methods: We analyzed hematological parameters and related-derivative indexes from 122 ESCC patients treated with NCRT followed by surgery. Univariate and multivariate Cox survival analyses were performed to identify independent prognostic factors to establish a nomogram and predict overall survival (OS). The predictive value of the nomogram for OS was evaluated by the concordance index (C-index), decision curve analysis (DCA), the clinical impact curve (CIC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI).Results: The pretreatment nutritional candidate, prognostic nutrition index, inflammation-related absolute monocyte count and TNM staging were entered into the nomogram for ESCC with NCRT followed by surgery. The C-index of the nomogram for OS was 0.790 (95% CI = 0.688– 0.893), which was higher than that of TNM staging (0.681; 95% CI = 0.565– 0.798, P = 0.026). The DCA, CIC, NRI, and IDI of the nomogram showed moderate improvement in predicting survival. Based on the cut point calculated according to the constructed nomogram, the high-risk group had poorer OS than that of the low-risk group (P < 0.05).Conclusion: A novel nomogram based on nutrition- and inflammation-related indicators might help predict the survival of ESCC treated with NCRT followed by surgery.Keywords: esophageal squamous cell carcinoma, neoadjuvant chemoradiotherapy, surgery, nomogram, survival, prognosis
first_indexed 2024-12-22T07:47:27Z
format Article
id doaj.art-fe54546a97b148e3a3bdc42e23273254
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-22T07:47:27Z
publishDate 2021-10-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-fe54546a97b148e3a3bdc42e232732542022-12-21T18:33:36ZengDove Medical PressCancer Management and Research1179-13222021-10-01Volume 137771778269622A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by SurgeryDing TLiu CHuang BChu LWei LLin YLuo YZhang BHong CXu YPeng YTianyan Ding1,2 &ast;, Cantong Liu1,2 &ast;, Binliang Huang,1,2 Lingyu Chu,1,2 Laifeng Wei,1,2 Yiwei Lin,1,2 Yun Luo,1,2 Biao Zhang,1,2 Chaoqun Hong,3 Yiwei Xu,1,2 Yuhui Peng1,2 1Department of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, Shantou, People’s Republic of China; 2Precision Medicine Research Center, Shantou University Medical College, Shantou, People’s Republic of China; 3Guangdong Provincial Key Laboratory of Breast Cancer Diagnosis and Treatment, Cancer Hospital of Shantou University Medical College, Shantou, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Yiwei XuDepartment of Clinical Laboratory Medicine, Cancer Hospital of Shantou University Medical College, 7 Raoping Road, Shantou, 515041, Guangdong, People’s Republic of ChinaFax +86-754-8856-0352Email yiwei512@126.comYuhui Peng Email pengyuhui666@163.comBackground: Neoadjuvant chemoradiotherapy (NCRT) followed by surgery is a component of the standard treatment for resectable locally advanced esophageal squamous cell carcinoma (ESCC), and the parameters for survival prediction are not clear yet. Our study aimed to construct a survival prediction nomogram for ESCC with NCRT followed by surgery.Methods: We analyzed hematological parameters and related-derivative indexes from 122 ESCC patients treated with NCRT followed by surgery. Univariate and multivariate Cox survival analyses were performed to identify independent prognostic factors to establish a nomogram and predict overall survival (OS). The predictive value of the nomogram for OS was evaluated by the concordance index (C-index), decision curve analysis (DCA), the clinical impact curve (CIC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI).Results: The pretreatment nutritional candidate, prognostic nutrition index, inflammation-related absolute monocyte count and TNM staging were entered into the nomogram for ESCC with NCRT followed by surgery. The C-index of the nomogram for OS was 0.790 (95% CI = 0.688– 0.893), which was higher than that of TNM staging (0.681; 95% CI = 0.565– 0.798, P = 0.026). The DCA, CIC, NRI, and IDI of the nomogram showed moderate improvement in predicting survival. Based on the cut point calculated according to the constructed nomogram, the high-risk group had poorer OS than that of the low-risk group (P < 0.05).Conclusion: A novel nomogram based on nutrition- and inflammation-related indicators might help predict the survival of ESCC treated with NCRT followed by surgery.Keywords: esophageal squamous cell carcinoma, neoadjuvant chemoradiotherapy, surgery, nomogram, survival, prognosishttps://www.dovepress.com/a-survival-prediction-nomogram-for-esophageal-squamous-cell-carcinoma--peer-reviewed-fulltext-article-CMAResophageal squamous cell carcinomaneoadjuvant chemoradiotherapysurgerynomogramsurvivalprognosis
spellingShingle Ding T
Liu C
Huang B
Chu L
Wei L
Lin Y
Luo Y
Zhang B
Hong C
Xu Y
Peng Y
A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
Cancer Management and Research
esophageal squamous cell carcinoma
neoadjuvant chemoradiotherapy
surgery
nomogram
survival
prognosis
title A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
title_full A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
title_fullStr A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
title_full_unstemmed A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
title_short A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery
title_sort survival prediction nomogram for esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy followed by surgery
topic esophageal squamous cell carcinoma
neoadjuvant chemoradiotherapy
surgery
nomogram
survival
prognosis
url https://www.dovepress.com/a-survival-prediction-nomogram-for-esophageal-squamous-cell-carcinoma--peer-reviewed-fulltext-article-CMAR
work_keys_str_mv AT dingt asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT liuc asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT huangb asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT chul asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT weil asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT liny asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT luoy asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT zhangb asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT hongc asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT xuy asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT pengy asurvivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT dingt survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT liuc survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT huangb survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT chul survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT weil survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT liny survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT luoy survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT zhangb survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT hongc survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT xuy survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery
AT pengy survivalpredictionnomogramforesophagealsquamouscellcarcinomatreatedwithneoadjuvantchemoradiotherapyfollowedbysurgery